BIOAGE LABS, INC. (BIOA) Debt / Equity
- 2025-12-31: Debt/Equity Ratio 0.01.
- 2025-09-30: Debt/Equity Ratio 0.01.
- 2025-06-30: Debt/Equity Ratio 0.02.
- 2025-03-31: Debt/Equity Ratio 0.02.
Complete source-backed debt/equity ratio history.
- Available history
- 2023-12-31 to 2025-12-31
- Data captured
Historical Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-31 | 0.01 |
| 2025-09-30 | 0.01 |
| 2025-06-30 | 0.02 |
| 2025-03-31 | 0.02 |
| 2024-12-31 | 0.03 |
| 2024-09-30 | 0.03 |
| 2023-12-31 | -0.08 |
Annual Debt/Equity Ratio
| Date | Debt/Equity Ratio |
|---|---|
| 2025-12-31 | 0.01 |
| 2024-12-31 | 0.03 |
| 2023-12-31 | -0.08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |